Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 20/20 | 0.65 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.65 |
| ▸ | PTGDR | Q13258 | 6/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.56 |
| ▸ | DRD2 | P14416 | 1/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15428826 | 1.00 | PTGDR2 (0.65) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL15428823 | 0.88 | PTGDR2 (0.63) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL17907989 | 0.88 | PTGDR2 (0.52) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL12355547 | 0.84 | PTGDR2 (0.64) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL15428831 | 0.83 | PTGDR2 (0.57) | PTGDR2TBXA2RPTGDR | |
| SCHEMBL22225179 | 0.82 | PTGDR2 (0.58) | PTGDR2TBXA2R | |
| SCHEMBL15428828 | 0.82 | PTGDR2 (0.60) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL15280008 | 0.82 | PTGDR2 (0.58) | PTGDR2TBXA2R | |
| SCHEMBL15428822 | 0.81 | PTGDR2 (0.61) | PTGDR2TBXA2RPTGDRCYP3A4CYP2C9 | |
| SCHEMBL16900671 | 0.81 | PTGDR2 (0.71) | PTGDR2TBXA2RPTGDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346865-B1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK CANADA INC (CA) | 2015-07-15 | — | — | EP | disclosed |
| US-8637671-B2 | Indole derivatives as CRTH2 receptor antagonists | MERCK CANADA INC. (CA) | 2014-01-28 | — | — | US | disclosed |
| WO-2010031183-A1 | INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS | MERCK FROSST CANADA LTD. (CA) | 2010-03-25 | — | — | WO | disclosed |